Ferraiuoli obtains Patent for: Method for Nanoliposomal c-MYC-siRNA Inhibits In Vivo Tumor Growth of Cisplatin-Resistant Ovarian Cancer
On February 20, 2018 the United States Patent and Trademark Office will publish patent number 9,895,312, titled Nanoliposomal c-MYC-siRNA Inhibits In Vivo Tumor Growth of Cisplatin-Resistant Ovarian Cancer prosecuted by Ferraiuoli for its client Pablo E. Vivias Mejia. Ferraiuoli wishes to congratulate Pablo E. Vivias Mejia on its new patent.
